Company profile
Inapill
Novel therapeutics targeting immunometabolism to defeat age-related chronic inflammatory and autoimmune disease
- Industry
- Biotechnology Research
- Employees
- 3
- Headquarters
- Berkeley, California
- Founded
- 2023
- LinkedIn followers
- 246
- Office locations
- 1
Inapill company summary
Inapill is a company in the Biotechnology Research industry, headquartered in Berkeley, California, founded in 2023. On LinkedIn the company has around 3 employees and 246 followers.
What technology does Inapill use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Inapill
Inapill is developing 1st-in-class, oral small molecule therapeutics targeting immune cell metabolism (immunometabolism) for improved treatment of age-related chronic inflammatory and autoimmune disease. Recent honors: -Creative Destruction Lab Advanced Therapies Program - 2025-26 cohort -California Life Sciences (CLS) FAST Advisory program - Spring 2025 cohort Inapill was co-founded by Greg Timblin, Josh Farahzad, and the therapeutics team @ General Inception (Palo Alto-based deep tech venture studio), and is a tenant at Bakar Bio Labs @ UC Berkeley.
Where is Inapill located?
Inapill lists 1 location.
Compare companies similar to Inapill
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Inapill inapill.com | Biotechnology Research | 3 | 2023 | Berkeley, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Inapill
What does Inapill do?
Inapill is developing 1st-in-class, oral small molecule therapeutics targeting immune cell metabolism (immunometabolism) for improved treatment of age-related chronic inflammatory and autoimmune disease. Recent honors: -Creative Destruction Lab Advanced Therapies Program - 2025-26 cohort -California Life Sciences (CLS) FAST Advisory program - Spring 2025 cohort Inapill was co-founded by Greg Timblin, Josh Farahzad, and the therapeutics team @ General Inception (Palo Alto-based deep tech venture studio), and is a tenant at Bakar Bio Labs @ UC Berkeley.
How many employees does Inapill have?
Inapill has around 3 employees on LinkedIn.
Where is Inapill headquartered?
Inapill is headquartered in Berkeley, California.
When was Inapill founded?
Inapill was founded in 2023.
Build a lead list from companies like Inapill
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.